✦ LIBER ✦

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

✍ Scribed by Stoeckle, Eberhard; Bourdarias, Lionnel; Guyon, Frédéric; Croce, Sabrina; Brouste, Véronique; Thomas, Laurence; Floquet, Anne

Book ID: 121547144
Publisher: Springer
Year: 2013
Tongue: English
Weight: 259 KB
Volume: 21
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3278-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Platinum-based Neoadjuvant

Comparison of Platinum-based Neoadjuvant Chemotherapy and Primary Debulking Surgery in Patients with Advanced Ovarian Cancer

✍ Sayyah-Melli, Manizheh; Zonoozi, Gita Kashi; Hashemzadeh, Shahryar; Esfahani, Al 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 375 KB

Histopathology predicts clinical outcome

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery

✍ Muraji, Miho; Sudo, Tamotsu; Iwasaki, Shin-ichi; Ueno, Sayaka; Wakahashi, Senn; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Bowel Resection at the Time of Primary D

Bowel Resection at the Time of Primary Debulking for Epithelial Ovarian Carcinoma: Outcomes in Patients Treated with Platinum and Taxane-Based Chemotherapy

✍ Jacob M. Estes; Charles A. Leath III; J. Michael Straughn Jr; Rodney P. Rocconi; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Five-year survival for cisplatin-based c

Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery

✍ M. Steven Piver; James Fanning; Henry E. Sprance 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The purpose of this study was to evaluate 5-year survival and 5-year progression-free survival in previously untreated patients with advanced ovarian cancer treated with single-agent melphalan in which very few patients underwent optimal debulking surgery (<2 cm residual) as compared with the patien

1708 DO MIXED HISTOLOGIC FEATURES AFFECT

1708 DO MIXED HISTOLOGIC FEATURES AFFECT SURVIVAL BENEFIT FROM NEO-ADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

✍ Messing, Edward; Scosyrev, Emelian; Ely, Benjamin; Speights, V.O.; Grossman, H. 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Common variants in ABCB1, ABCC2 and ABCG

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study

✍ Chunqiao Tian; Christine B. Ambrosone; Kathleen M. Darcy; Thomas C. Krivak; Debo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 572 KB